Last mentioned: Mar 19, 2026
Earnings Call
Management hosts a conference call to discuss 2025 performance and 2026 outlook.
Earnings Call Highlights
Management teams discuss forward-looking guidance and strategic shifts for 2026.
Financial Reporting
XOMA files Q4 and Full Year 2025 financial results with the SEC.
Q4 Earnings Release
Both XOMA and Canadian Solar file results of operations for the fiscal year end.
Asset Acquisition
Completion of a significant acquisition of royalty rights from a clinical-stage partner.
XOMA Asset Acquisition
Completion of a significant acquisition of royalty interests in clinical-stage assets.
XOMA Leadership Update
Company files 8-K regarding director elections and governance updates.
Strategic Disclosure
XOMA issues Regulation FD disclosure regarding portfolio updates.
XOMA Royalty and Canadian Solar reported Q4 results highlighting a strategic shift toward high-margin recurring revenue and energy storage, respectively. While XOMA capitalizes on a maturing biotech royalty portfolio, Canadian Solar is navigating a volatile solar module market by scaling its e-STORAGE division.
Canadian Solar's Q4 results signal a strategic pivot toward high-margin energy storage and project development to mitigate module price volatility. Simultaneously, XOMA Royalty's earnings highlight the continued strength of the royalty-based financing model in a high-interest-rate environment.
XOMA Royalty reported its Q4 and full-year 2025 financial results, highlighting a significant expansion of its royalty portfolio and the continued commercial success of key assets like Vabysmo and Daybue. The company remains focused on its strategic pivot toward becoming a pure-play royalty aggregator in the biotechnology sector.